Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Adma biologics inc crawled time : 11:00 save search
ADMA Biologics Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV™ & BIVIGAM®
Published: 2024-03-11 (Crawled : 11:00) - globenewswire.com
ADMA 4 | $6.465 -1.15% -1.16% 1.7M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -2.52%
bivigam fda
ADMA Biologics to Report Third Quarter 2023 Financial Results on November 8, 2023
Published: 2023-11-01 (Crawled : 11:00) - globenewswire.com
ADMA 4 | $6.465 -1.15% -1.16% 1.7M
|
Health Technology
|
| O: 0.0%
H: 4.14%
C: 4.14%
report financial results
ADMA Biologics to Report Second Quarter 2023 Financial Results on August 9, 2023
Published: 2023-08-02 (Crawled : 11:00) - globenewswire.com
ADMA 4 | $6.465 -1.15% -1.16% 1.7M
|
Health Technology
|
| O: -0.24%
H: 0.24%
C: -1.22%
report financial results
ADMA BioCenters Receives FDA Approval for its Ninth Plasma Collection Center, Located in Dallas, GA
Published: 2023-07-19 (Crawled : 11:00) - globenewswire.com
ADMA 4 | $6.465 -1.15% -1.16% 1.7M
|
Health Technology
|
| O: 1.68%
H: 7.99%
C: 3.03%
fda approval
ADMA Biologics to Report First Quarter 2023 Financial Results on May 10, 2023
Published: 2023-05-03 (Crawled : 11:00) - globenewswire.com
ADMA 4 | $6.465 -1.15% -1.16% 1.7M
|
Health Technology
|
| O: 0.91%
H: 6.16%
C: 4.5%
report financial results
ADMA Biologics Announces Amendment to Credit Agreement
Published: 2023-05-02 (Crawled : 11:00) - globenewswire.com
ADMA 4 | $6.465 -1.15% -1.16% 1.7M
|
Health Technology
|
| O: 0.29%
H: 0.44%
C: -3.79%
agreement
ADMA Biologics to Report Fourth Quarter and Full Year 2022 Financial Results on March 23, 2023
Published: 2023-03-16 (Crawled : 11:00) - admabiologics.com
ADMA 4 | $6.465 -1.15% -1.16% 1.7M
|
Health Technology
|
| O: -0.64%
H: 2.57%
C: 0.64%
report year financial results
ADMA Biologics to Report Third Quarter 2022 Financial Results on November 9, 2022
Published: 2022-11-02 (Crawled : 11:00) - admabiologics.com
ADMA 4 | $6.465 -1.15% -1.16% 1.7M
|
Health Technology
|
| O: 0.72%
H: 0.0%
C: -5.04%
report financial results
ADMA BioCenters Receives FDA Approval for its Seventh Plasma Collection Center, Located in Greensboro, NC
Published: 2022-10-31 (Crawled : 11:00) - admabiologics.com
ADMA 4 | $6.465 -1.15% -1.16% 1.7M
|
Health Technology
|
| O: 0.71%
H: 0.26%
C: -0.7%
fda approval
ADMA Biologics to Report Second Quarter 2022 Financial Results on August 10, 2022
Published: 2022-08-03 (Crawled : 11:00) - admabiologics.com
ADMA 4 | $6.465 -1.15% -1.16% 1.7M
|
Health Technology
|
| O: 0.96%
H: 0.83%
C: -0.47%
report results
ADMA Biologics Announces Addition to the Russell 2000® Index
Published: 2022-06-21 (Crawled : 11:00) - admabiologics.com
ADMA 4 | $6.465 -1.15% -1.16% 1.7M
|
Health Technology
|
| O: 12.13%
H: 0.0%
C: 0.0%
2000 index
ADMA Biologics to Report First Quarter 2022 Financial Results on May 11, 2022
Published: 2022-05-04 (Crawled : 11:00) - admabiologics.com
ADMA 4 | $6.465 -1.15% -1.16% 1.7M
|
Health Technology
|
| O: 2.09%
H: 3.08%
C: 1.54%
report results
ADMA Announces Live Poster Presentation and Symposium on Real-World Experience with ASCENIV™ at CIS 2022
Published: 2022-04-01 (Crawled : 11:00) - admabiologics.com
ADMA 4 | $6.465 -1.15% -1.16% 1.7M
|
Health Technology
|
| O: 0.0%
H: 8.74%
C: 3.83%
symposium presentation
ADMA Biologics Announces FDA Approval of Extended Shelf Life for ASCENIV™ & BIVIGAM® from 24 to 36 Months
Published: 2022-03-25 (Crawled : 11:00) - admabiologics.com
ADMA 4 | $6.465 -1.15% -1.16% 1.7M
|
Health Technology
|
| O: 1.33%
H: 7.24%
C: 7.24%
bivigam fda approval
ADMA Biologics to Report Fourth Quarter and Full Year 2021 Financial Results on March 24, 2022
Published: 2022-03-21 (Crawled : 11:00) - admabiologics.com
ADMA 4 | $6.465 -1.15% -1.16% 1.7M
|
Health Technology
|
| O: -1.75%
H: 1.19%
C: -7.14%
financial results report results
ADMA Biologics to Report Third Quarter 2021 Financial Results on November 10, 2021
Published: 2021-11-03 (Crawled : 11:00) - admabiologics.com
ADMA 4 | $6.465 -1.15% -1.16% 1.7M
|
Health Technology
|
| O: 2.94%
H: 6.43%
C: 6.43%
financial results results
ADMA Biologics Announces Data Presented at the 2021 ISIRV-WHO Conference
Published: 2021-10-22 (Crawled : 11:00) - admabiologics.com
ADMA 4 | $6.465 -1.15% -1.16% 1.7M
|
Health Technology
|
| O: -2.48%
H: 10.17%
C: 8.47%
conference
ADMA Biologics Announces a Poster Presentation at the 2021 International Society for Influenza and other Respiratory Virus Diseases - World Health Organization Conference
Published: 2021-10-19 (Crawled : 11:00) - admabiologics.com
ADMA 4 | $6.465 -1.15% -1.16% 1.7M
|
Health Technology
|
| O: 0.91%
H: 1.8%
C: 0.0%
presentation disease respiratory influenza conference
ADMA Biologics Strengthens its Board of Directors with the Appointment of Young T. Kwon, Ph.D.
Published: 2021-10-18 (Crawled : 11:00) - admabiologics.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.49%
H: 0.4%
C: -0.08%
ADMA 4 | $6.465 -1.15% -1.16% 1.7M
|
Health Technology
|
| O: -0.45%
H: 0.9%
C: -0.9%
ADMA Biologics Announces the Presentation of Real-World Experience in the Management of Respiratory Syncytial Virus (RSV) Presented at IDWeek 2021
Published: 2021-10-04 (Crawled : 11:00) - admabiologics.com
ADMA 4 | $6.465 -1.15% -1.16% 1.7M
|
Health Technology
|
| O: 2.65%
H: 0.86%
C: -0.86%
presentation respiratory
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.